Boston Scientific (BSX) closed the most recent trading day at $99.22, moving +0.32% from the previous trading session. This move outpaced the S&P 500's daily loss of 1.07%. Meanwhile, the Dow lost ...

Boston Scientific has shown high revenue and EPS growth rates in recent years. See why I recommend a hold rating for BSX stock.

This was the stock's second consecutive day of gains.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

Boston Metal, a supplier of steel decarbonization technology, has successfully commissioned its multi-inert anode Molten ...

Boston Scientific’s stock surged 40.6% in the past year, far outpacing the broader market. This growth stems from strong ...

The stock's fall snapped a two-day winning streak.

Lila Sciences has secured $200 million in seed funding from Flagship Pioneering, which incubated the company, and General ...

Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.

Today's Research Daily features new research reports on 16 major stocks, including The Goldman Sachs Group, Inc. (GS), The Progressive Corp. (PGR) and Boston Scientific Corp. (BSX), as well as ...

The United States has historically made substantial scientific and monetary contributions to the IPCC. US scientists publish research that informs the assessment and run computer simulations of ...